Jonathan Allan - Net Worth and Insider Trading

Jonathan Allan Net Worth

The estimated net worth of Jonathan Allan is at least $33,670 dollars as of 2024-11-05. Jonathan Allan is the GENERAL COUNSEL & CORP SEC of Stoke Therapeutics Inc and owns about 2,598 shares of Stoke Therapeutics Inc (STOK) stock worth over $33,670. Details can be seen in Jonathan Allan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jonathan Allan has not made any transactions after 2024-05-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jonathan Allan

To

Jonathan Allan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jonathan Allan owns 1 companies in total, including Stoke Therapeutics Inc (STOK) .

Click here to see the complete history of Jonathan Allan’s form 4 insider trades.

Insider Ownership Summary of Jonathan Allan

Ticker Comapny Transaction Date Type of Owner
STOK Stoke Therapeutics Inc 2024-05-20 General Counsel & Corp Sec

Jonathan Allan Latest Holdings Summary

Jonathan Allan currently owns a total of 1 stock. Jonathan Allan owns 2,598 shares of Stoke Therapeutics Inc (STOK) as of May 20, 2024, with a value of $33,670.

Latest Holdings of Jonathan Allan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
STOK Stoke Therapeutics Inc 2024-05-20 2,598 12.96 33,670

Holding Weightings of Jonathan Allan


Jonathan Allan Form 4 Trading Tracker

According to the SEC Form 4 filings, Jonathan Allan has made a total of 4 transactions in Stoke Therapeutics Inc (STOK) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Stoke Therapeutics Inc is the sale of 8,599 shares on May 20, 2024, which brought Jonathan Allan around $129,329.

Insider Trading History of Jonathan Allan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jonathan Allan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jonathan Allan Ownership Network

Ownership Network List of Jonathan Allan

No Data

Ownership Network Relation of Jonathan Allan

Insider Network Chart

Jonathan Allan Owned Company Details

What does Stoke Therapeutics Inc do?

Who are the key executives at Stoke Therapeutics Inc?

Jonathan Allan is the General Counsel & Corp Sec of Stoke Therapeutics Inc. Other key executives at Stoke Therapeutics Inc include Chief Medical Officer Barry Ticho , 10 percent owner Skorpios Trust , and COO & CBO Huw M. Nash .

Stoke Therapeutics Inc (STOK) Insider Trades Summary

Over the past 18 months, Jonathan Allan made 4 insider transaction in Stoke Therapeutics Inc (STOK) with a net sale of 18,022. Other recent insider transactions involving Stoke Therapeutics Inc (STOK) include a net sale of 124,116 shares made by Barry Ticho , a net sale of 56,616 shares made by Huw M. Nash , and a net sale of 5,537,500 shares made by Skorpios Trust .

In summary, during the past 3 months, insiders sold 1,957,500 shares of Stoke Therapeutics Inc (STOK) in total and bought 0 shares, with a net sale of 1,957,500 shares. During the past 18 months, 5,793,870 shares of Stoke Therapeutics Inc (STOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,793,870 shares.

Stoke Therapeutics Inc (STOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Stoke Therapeutics Inc Insider Transactions

No Available Data

Jonathan Allan Mailing Address

Above is the net worth, insider trading, and ownership report for Jonathan Allan. You might contact Jonathan Allan via mailing address: C/o Stoke Therapeutics, Inc., 45 Wiggins Avenue, Bedford Ma 01730.